IRCT2013032212197N5已完成2 期
Effect of Pamidronate on bone pains in patients with Malignancy
Vice chancellor for research of Tonekabon Islamic Azad University0 个研究点目标入组 41 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 41
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Malignancy with bone metastasis
- •Exclusion criteria:
- •Renal dysfunction history,
- •Creatinine more than 2mg/dl,
- •Treatment of Hypocalcemia with other Bisphosphonates
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
The effect of pamidronate treatment on bone health in patients with neuromuscular disease undergoing hip surgery. - Using pamidronate in patients with CP undergoing hip surgery.Children with neuromuscular conditions undergoing hip surgery. Aiming to identify whether pamidronate a licenced medicine mainatins bone mineral density in patients with neuromuscular conditions undergoing hip surgery.EUCTR2009-013777-17-GBCentral Manchester and Manchester University Children's Hospital NHS Trust.12
已完成
4 期
Effect of bisphosphonate on osteoporosis in kidney transplant patientskidney transplant patients with low bone mineral density.Kidney transplant statusIRCT138804162109N1Ahvaz Jundishapur University of Medical Sciences40
已完成
不适用
Effect of pamidronate on bone loss and implant stability after total hip arthroplastyPeriprosthetic bone loss after total hip replacementMusculoskeletal DiseasesPeriprosthetic bone lossISRCTN37786144Arthritis Research Campaign (ARC) (UK)
招募中
3 期
Pamidronate for pain in adult chronic nonbacterial osteitis (PAM-CNO): a randomized, double-blind, placebo-controlled trialSAPHO-syndromesterile bone inflammation10005959NL-OMON52471eids Universitair Medisch Centrum70
招募中
3 期
PAmidronate for Pain in Sternocostoclavicular hyperostosis: the PAPS-study, a double-blind randomized placebo-controlled trial2023-510309-16-00Academisch Ziekenhuis Leiden70